相关实验视频
Updated: Jul 13, 2025

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
25.2K
外基因组:胰腺癌药物耐药性的新兴调节器
Marzia Di Donato1, Nicola Medici1, Antimo Migliaccio1
1Department of Precision Medicine, University of Campania "L.Vanvitelli", Via L. De Crecchio 7, 80138 Naples, Italy.
Cancers
|October 14, 2023
概括
胰腺癌 (PaC) 耐药性是一个重大挑战. 外体,细胞释放的微小囊泡,转移分子,帮助PaC细胞逃避化疗,恶化患者的结果.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 胰腺癌 (PaC) 是一种高度致命的恶性瘤,治疗选择有限.
- 目前的治疗方法如gemcitabine,nab-paclitaxel和FOLFIRINOX通常由于早期耐药性而失败.
- 目前尚不完全了解PAC耐药性背后的机制,这阻碍了有效的治疗策略.
研究的目的:
- 审查外体在调解胰腺癌耐药性的作用.
- 阐明外体细胞对PaC中化学疗法逃避有助的机制.
- 提供当前PaC药理学方法和外体驱动耐药性的概述.
主要方法:
- 胰腺癌治疗和外体生物学的文献综述.
- 对研究癌症中外体介导细胞间通信的研究进行分析.
- 综合有关外体荷载及其对药物敏感性的影响的信息.
主要成果:
- 外体是PaC中细胞间通信的关键媒介.
- 耐药性PaC细胞释放出外体,这些外体将耐药性传递分子转移到敏感细胞中.
- 外体细胞对凝胺和其他化疗耐药性的发展和进展做出了重大贡献.
结论:
- 外体在胰腺癌药物耐药性的发展中起着至关重要的作用.
- 向外体生物发生或功能是一个潜在的治疗策略,以克服PaC化学抵抗.
- 对外体细胞与癌细胞相互作用的进一步研究对于改善PaC治疗结果至关重要.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.3K
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.7K
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K